A citation-based method for searching scientific literature

Baoliang Guo, Daisuke Koya, Motohide Isono, Toshiro Sugimoto, Atsunori Kashiwagi, Masakazu Haneda. Diabetes 2004
Times Cited: 112







List of co-cited articles
687 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Heather A Burgess, Louis Eugene Daugherty, Thomas H Thatcher, Heather F Lakatos, Denise M Ray, Michelle Redonnet, Richard P Phipps, Patricia J Sime. Am J Physiol Lung Cell Mol Physiol 2005
243
16

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.
Feng Zheng, Alessia Fornoni, Sharon J Elliot, Youfei Guan, Matthew D Breyer, Liliane J Striker, Gary E Striker. Am J Physiol Renal Physiol 2002
112
15




Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
Stephen Zafiriou, Scott R Stanners, Sonia Saad, Tania S Polhill, Philip Poronnik, Carol A Pollock. J Am Soc Nephrol 2005
96
13

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
K J McCarthy, R E Routh, W Shaw, K Walsh, T C Welbourne, J H Johnson. Kidney Int 2000
90
14

Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Asish K Ghosh, Swati Bhattacharyya, Gabriella Lakos, Shu-Jen Chen, Yasuji Mori, John Varga. Arthritis Rheum 2004
160
12

hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
Yingjian Li, Xiaoyan Wen, Bradley C Spataro, Kebin Hu, Chunsun Dai, Youhua Liu. J Am Soc Nephrol 2006
114
12

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
B M Forman, P Tontonoz, J Chen, R P Brun, B M Spiegelman, R M Evans. Cell 1995
11

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
S B Nicholas, Y Kawano, S Wakino, A R Collins, W A Hsueh. Hypertension 2001
107
10


Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
Robert Earl Routh, John Hardwick Johnson, Kevin John McCarthy. Kidney Int 2002
50
20

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
Hui Zhang, Aihua Zhang, Donald E Kohan, Raoul D Nelson, Frank J Gonzalez, Tianxin Yang. Proc Natl Acad Sci U S A 2005
273
10

PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose.
U Panchapakesan, S Sumual, C A Pollock, X Chen. Am J Physiol Renal Physiol 2005
82
12



Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
E Imano, T Kanda, Y Nakatani, T Nishida, K Arai, M Motomura, Y Kajimoto, Y Yamasaki, M Hori. Diabetes Care 1998
162
9

Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients.
T Nakamura, C Ushiyama, N Shimada, K Hayashi, I Ebihara, H Koide. J Diabetes Complications 2000
124
9

Rosiglitazone reduces urinary albumin excretion in type II diabetes.
G Bakris, G Viberti, W M Weston, M Heise, L E Porter, M I Freed. J Hum Hypertens 2003
200
9

Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats.
T Yoshimoto, M Naruse, M Nishikawa, K Naruse, A Tanabe, T Seki, T Imaki, R Demura, E Aikawa, H Demura. Am J Physiol 1997
98
9


PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
Caiyan Zhao, Wei Chen, Liu Yang, Lihong Chen, Stephen A Stimpson, Anna Mae Diehl. Biochem Biophys Res Commun 2006
114
9

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats.
R E Buckingham, K A Al-Barazanji, C D Toseland, M Slaughter, S C Connor, A West, B Bond, N C Turner, J C Clapham. Diabetes 1998
175
8

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
T Asano, M Wakisaka, M Yoshinari, K Iino, K Sonoki, M Iwase, M Fujishima. Biochim Biophys Acta 2000
77
10

Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses.
Stephen Zafiriou, Scott R Stanners, Tania S Polhill, Philip Poronnik, Carol A Pollock. Kidney Int 2004
61
13

Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
Feng-qin Dong, Hong Li, Wei-min Cai, Jun Tao, Qun Li, Yu Ruan, Fen-ping Zheng, Zhe Zhang. Chin Med J (Engl) 2004
39
20

A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.
Rajiv Agarwal, Chandan Saha, Meher Battiwala, Nina Vasavada, Timothy Curley, Shawn D Chase, Nadine Sachs, Merfake H Semret. Kidney Int 2005
58
13


Biphasic vasodilator action of troglitazone on the renal microcirculation.
Shuji Arima, Kentaro Kohagura, Kazuhisa Takeuchi, Yoshihiro Taniyama, Akira Sugawara, Yukio Ikeda, Michiaki Abe, Ken Omata, Sadayoshi Ito. J Am Soc Nephrol 2002
44
18

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
J M Lehmann, L B Moore, T A Smith-Oliver, W O Wilkison, T M Willson, S A Kliewer. J Biol Chem 1995
8


TGF-beta signaling and the fibrotic response.
Andrew Leask, David J Abraham. FASEB J 2004
8

Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
Jian Song, Mark A Knepper, Xinqun Hu, Joseph G Verbalis, Carolyn A Ecelbarger. J Pharmacol Exp Ther 2004
113
7

Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria.
T Nakamura, C Ushiyama, S Osada, M Hara, N Shimada, H Koide. Metabolism 2001
105
7

Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.
Akira Onozaki, Sanae Midorikawa, Hironobu Sanada, Yoshimitsu Hayashi, Tsuneharu Baba, Tetsuo Katoh, Tsuyoshi Watanabe. Biochem Biophys Res Commun 2004
32
21

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lef√®bvre, Gordon D Murray,[...]. Lancet 2005
7


Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.
Frank Pistrosch, Kay Herbrig, Beate Kindel, Jens Passauer, Sabine Fischer, Peter Gross. Diabetes 2005
121
7

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.
YouFei Guan, Chuanming Hao, Dae Ryong Cha, Reena Rao, Wendell Lu, Donald E Kohan, Mark A Magnuson, Reyadh Redha, Yahua Zhang, Matthew D Breyer. Nat Med 2005
467
7



PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.
Xiong Z Ruan, John F Moorhead, Ray Fernando, David C Wheeler, Stephen H Powis, Zac Varghese. J Am Soc Nephrol 2003
92
7

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
D S Straus, G Pascual, M Li, J S Welch, M Ricote, C H Hsiang, L L Sengchanthalangsy, G Ghosh, C K Glass. Proc Natl Acad Sci U S A 2000
900
7


PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
Jami E Milam, Venkateshwar G Keshamouni, Sem H Phan, Biao Hu, Srinivasa R Gangireddy, Cory M Hogaboam, Theodore J Standiford, Victor J Thannickal, Raju C Reddy. Am J Physiol Lung Cell Mol Physiol 2008
146
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.